Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00456222 · ClinicalTrials.gov registry record
Impact of Sleep Disruption on the Menstrual Cycle
A clinical trial, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- 18
- Enrollment target
NCT00456222: Completed study, sponsored by Brigham and Women's Hospital.
NCT00456222 is a clinical trial that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 18 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00456222 has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- 18 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate whether sleep disruption affects menstrual cycle timing
Interventions
- BEHAVIORAL Disrupting or changing the timing or the duration of sleep
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2003-06 |
| Est. Completion | 2009-08 |
What the finished NCT00456222 record still lists
NCT00456222 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 18 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Disrupting or changing the timing or the duration of sleep is the first listed.
NCT00456222 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00456222 about?
NCT00456222 is a clinical study titled "Impact of Sleep Disruption on the Menstrual Cycle". The purpose of this study is to investigate whether sleep disruption affects menstrual cycle timing
What is the current status of trial NCT00456222?
This trial is currently completed. The enrollment target is 18 participants. The study started on 2003-06. Estimated completion is 2009-08.
What interventions are being tested in trial NCT00456222?
The interventions under investigation include: Disrupting or changing the timing or the duration of sleep (BEHAVIORAL).
Who is sponsoring clinical trial NCT00456222?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia